Platelet glycoprotein Ilb/IIIa inhibition with integrelin during percutaneous coronary intervention:the IMPACT II trial - Tcheng, JE; Lincoff, AM; Sigmon, KN; for the Impact II Investigators (Circulation, 1995)
abstract